Komori
Meidensha (6508) · FactInterim research and development expenses increased from ¥5,363 million to ¥6,724 million

¥6,959 million spent on research and development

First written in FY2018-Q3. 15 of 22 entries say "Restated". Latest entry: FY2026-H1.

22entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019-Q1 – FY2021-Q3RestatedFY2022-Q1 – FY2026-H12018: 420182019: 420192020: 220202021: 420212022: 220222023: 320232024: 220242025: 12025
Same theme, other companies
Continuation of R&D activities with no change in statusA theme 205 companies write about · 0 as a headwind · 194 as a tailwind

50 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 209 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1Interim research and development expenses increased from ¥5,363 million to ¥6,724 millionAnnual report

    「The Group's total research and development activities for the six months ended the interim period amounted to ¥6,724 million.」

    Research and development activities increased from ¥5,363 million in the same period of the previous year to ¥6,724 million. The company stated that there were no material changes in the status of its research and development activities.
  2. FY2025-H1RestatedAnnual report

    「The Group's total research and development activities for the six months ended the interim period amounted to ¥5,363 million. There were no material changes in the status of the Group's research and development activities during the six months ended the interim period.」

    The company disclosed research and development activities of ¥5,363 million for the six months ended the interim period and stated that there were no material changes in the status of those activities.
  3. FY2024-Q3RestatedAnnual report

    「The Group's total research and development activities for the nine months ended the third quarter amounted to ¥7,498 million. There were no material changes in the status of the Group's research and development activities during the nine months ended the third quarter.」

    The company disclosed research and development activities of ¥7,498 million for the nine months ended the third quarter and stated that there were no material changes in the status of those activities.
  4. FY2024-Q2RestatedAnnual report

    「The Group's total research and development activities for the six months ended the second quarter amounted to ¥5,015 million. There were no material changes in the status of the Group's research and development activities during the six months ended the second quarter.」

    The company disclosed research and development activities of ¥5,015 million for the six months ended the second quarter and stated that there were no material changes in the status of those activities.
  5. FY2024-Q1RestatedAnnual report

    「The Group's total research and development activities for the three months ended the first quarter amounted to ¥2,324 million. There were no material changes in the status of the Group's research and development activities during the three months ended the first quarter.」

    The company disclosed research and development activities of ¥2,324 million for the first quarter and stated that there were no material changes in the status of those activities.
  6. FY2023-Q3RestatedAnnual report

    「The Group's total research and development activities for the nine months ended the third quarter amounted to ¥7,408 million. There were no material changes in the status of the Group's research and development activities during the nine months ended the third quarter.」

    The company disclosed research and development activities of ¥7,408 million for the nine months ended the third quarter and stated that there were no material changes in the status of those activities.
  7. FY2023-Q2RestatedAnnual report

    「The Group's total research and development activities for the six months ended the second quarter amounted to ¥5,040 million. There were no material changes in the status of the Group's research and development activities during the six months ended the second quarter.」

    The company disclosed research and development activities of ¥5,040 million for the six months ended the second quarter and stated that there were no material changes in the status of those activities.
  8. FY2023-Q1RestatedAnnual report

    「The Group's total research and development activities for the three months ended the first quarter amounted to ¥2,136 million. There were no material changes in the status of the Group's research and development activities during the three months ended the first quarter.」

    The company disclosed research and development activities of ¥2,136 million for the first quarter and stated that there were no material changes in the status of those activities.
  9. FY2022-Q2RestatedAnnual report

    「The Group's total research and development activities for the six months ended the second quarter amounted to ¥4,524 million. There were no material changes in the status of the Group's research and development activities during the six months ended the second quarter.」

    The company disclosed research and development activities of ¥4,524 million for the six months ended the second quarter and stated that there were no material changes in the status of those activities.
  10. FY2022-Q1RestatedAnnual report

    「The Group's total research and development activities for the three months ended the first quarter amounted to ¥1,869 million. There were no material changes in the status of the Group's research and development activities during the three months ended the first quarter.」

    The company disclosed research and development activities of ¥1,869 million for the first quarter and stated that there were no material changes in the status of those activities.
  11. FY2021AdvancedAnnual report

    「Total research and development expenses for the fiscal year amounted to ¥9,468 million, equivalent to 4.1% of consolidated net sales.」

    Disclosure progressed from research and development expenses of ¥6,874 million for the nine months ended the third quarter to full-year research and development expenses of ¥9,468 million, or 4.1% of net sales.
  12. FY2021-Q3Research and development expenses of ¥6,874 million for the nine months ended the third quarterAnnual report

    「The Group's total research and development activities for the nine months ended the third quarter amounted to ¥6,874 million. There were no material changes in the status of the Group's research and development activities during the nine months ended the third quarter.」

    The company disclosed research and development activities of ¥6,874 million for the nine months ended the third quarter and stated that there were no material changes in the status of those activities.
  13. FY2021-Q2Research and development expenses of ¥4,761 million for the six months ended the second quarterAnnual report

    「The amount spent on research and development activities by the Group as a whole during the six months ended the second quarter of the current consolidated fiscal year was ¥4,761 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company disclosed research and development spending of ¥4,761 million for the six months ended the second quarter and stated that there were no material changes in the status of these activities.
  14. FY2021-Q1RestatedAnnual report

    「The amount spent on research and development activities by the Group as a whole during the three months ended the first quarter of the current consolidated fiscal year was ¥2,001 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company disclosed research and development spending of ¥2,001 million for the first quarter and stated that there were no material changes in its research and development activities.
  15. FY2020-Q2RestatedAnnual report

    「The amount spent on research and development activities by the Group as a whole during the six months ended the second quarter of the current consolidated fiscal year was ¥5,342 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company disclosed research and development spending of ¥5,342 million for the six months ended the second quarter and stated that there were no material changes in the status of these activities.
  16. FY2020-Q1RestatedAnnual report

    「The amount spent on research and development activities by the Group as a whole during the three months ended the first quarter of the current consolidated fiscal year was ¥2,274 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company disclosed research and development spending of ¥2,274 million for the first quarter and stated that there were no material changes in its research and development activities.
  17. FY2019Full-year research and development expenses increased to ¥9,458 millionAnnual report

    「Research and development expenses for the current consolidated fiscal year were ¥9,458 million, equivalent to 3.9% of consolidated net sales.」

    Full-year research and development expenses increased from ¥9,402 million in the previous fiscal year to ¥9,458 million, accounting for 3.9% of consolidated net sales.
  18. FY2019-Q3RestatedAnnual report

    「The amount spent on research and development activities by the Group as a whole during the nine months ended the third quarter of the current consolidated fiscal year was ¥6,971 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company disclosed research and development spending of ¥6,971 million for the nine months ended the third quarter and stated that there were no material changes in the status of these activities.
  19. FY2019-Q2RestatedAnnual report

    「The amount spent on research and development activities by the Group as a whole during the six months ended the second quarter of the current consolidated fiscal year was ¥4,619 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company disclosed research and development spending of ¥4,619 million for the six months ended the second quarter and stated that there were no material changes in the status of these activities.
  20. FY2019-Q1RestatedAnnual report

    「The amount spent on research and development activities by the Group as a whole during the three months ended the first quarter of the current consolidated fiscal year was ¥1,928 million. There were no material changes in the status of the Group's research and development activities during the period.」

    The company disclosed research and development spending of ¥1,928 million for the first quarter and stated that there were no material changes in its research and development activities.
  21. FY2018AdvancedAnnual report

    「Research and development expenses for the current consolidated fiscal year were ¥9,402 million, equivalent to 3.9% of consolidated net sales.」

    The disclosure has progressed from ¥6,959 million in research and development spending for the nine months ended the third quarter to full-year expenses of ¥9,402 million, equivalent to 3.9% of net sales.
  22. FY2018-Q3First statedAnnual report

    「The amount spent on research and development activities by the Group as a whole during the nine months ended the third quarter of the current consolidated fiscal year was ¥6,959 million.」

    The company disclosed that the Group's total research and development spending for the nine months ended the third quarter was ¥6,959 million.
Moved together

"Growth and expansion in the overseas business" moved the same way as this thread, in the same document, in 2 of its 22 moves.

22★12
  1. ★This thread
  2. 1Growth and expansion in the overseas business2×
  3. 2Making Prime Meiden Ltd. a subsidiary and establishing it as a strategic production and procurement base2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Meidensha's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.